Is anyone involved in clinical trials for ET, specifically for CALR?
Is anyone involved in any clinical trials for ET, specifically for CALR? I am unable to tolerate Hydroxyurea, and am currently only taking aspirin. I saw this one: “JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms” on clinical trials.gov and other cancer center sites.
Interested in more discussions like this? Go to the Blood Cancers & Disorders Support Group.
Connect

@drbart86, hola, espero te encuentres bien. Quisiera saber como fue tu intolerancia a la hidroxiurea?
View Translation
@drbart86
A friend with ALS volunteered for a drug trial. It was a heroic choice, but absolutely horrible for her. Her ALS progressed very quickly; she had less than a year after diagnosis.
Participating in the trial meant taking 10 (extra) pills a day as well as multiple two-hour trips to the clinic. Worst of all, it meant she couldn't take a medication to ease a heartbreaking symptom of ALS, uncontrollable sobbing. That wasn't disclosed when she signed up for the trial.
Please be sure you fully understand what this drug trial would entail.
I appreciate your comments.
-
Like -
Helpful -
Hug
1 Reaction@cathy8
It is interesting for me to hear that you have both CALR and Jak2. I was initially diagnosed with ET CALR mutation in 2022. Last year my oncologist left, so I reached out to the Mayo in Phoenix and was accepted as a patient. After running tests on me, my oncologist told me I have Jak2. On my next appointment, they will test the proportion of mutation. From the start I have been on small dosage of Anagrelide. At first I had heart palpitations, but after a short time no longer experienced that, no other side effects, and has brought my platelets down to 383 from a high of 600. My oncologist at the Mayo will be switching me to Hydroxyura 500 mg 3 x week. (Less long term side effects?) I hope you will get past feeling severely tired - that is a difficult way to spend every day.
-
Like -
Helpful -
Hug
2 ReactionsI am in the JNJ-88549968 trial for ET/Myelofibrosis caused by the mutations in the CALR gene.
-
Like -
Helpful -
Hug
1 ReactionI have ET-CALR and am intolerant to Hydroxyurea. I am waiting to see if I will be accepted to a clinical trial for INCA033989 at MD Anderson.
-
Like -
Helpful -
Hug
4 ReactionsI have ET / CALR and it took 18 mo for my platelets to go from 1.1m to 400k.
It was a long yr until side effects subsided. Thank goodness for supermarket / pharmacy delivery!
I’ve now reduced hydrea from 500mg daily to 3x per week.
I recently had other medical issues and learned pain can cause platelet count to jump 100 points.
Don’t be surprised (like I was) if your platelet count fluctuates.
I hope the clinical trial works well.
Please keep us informed and good luck!
-
Like -
Helpful -
Hug
6 Reactions@lisanell Thank you for participating in the trial. Hopes are high for INCA033989.
-
Like -
Helpful -
Hug
3 ReactionsHi @nohrt4me ,
That is the one I am interested in too.
-
Like -
Helpful -
Hug
1 ReactionQuick update. Still on the Merck trial (control) but have had to ups my dose of Jakafi to 15 mg/2x/d as the 10 mg/2x/d was not helping. Hoping to get on the JNJ-88549968 trial soon. This treatment may be one of the best options to a cure for the CALR mutation. Incyte is also starting trials with a similar mode of action.
https://www.ctsearchsupport.org/clinical-trials/a-study-of-jnj-88549968-for-the-treatment-of-calreticulin-calr-mutated-myeloproliferative-neoplasms
-
Like -
Helpful -
Hug
4 Reactions